Tenfold Growth Foreseen for Global Telehealth Market
|
By HospiMedica International staff writers Posted on 02 Feb 2014 |
The global telehealth market is expected to grow by more than a factor of 10 by 2018, as medical providers increasingly employ remote communications and monitoring technology to reduce costs and improve the quality of care. These are the latest findings of IHS (Englewood, CO, USA), a leading global source of critical information and insight.
Telehealth, defined as the use of medical devices and communication technology together to monitor diseases and symptoms, offers scalable healthcare in a cost-efficient way at a time of increasing pressure on the healthcare sector for personnel and resources. It is especially helpful in managing the chronic conditions of those aged 65 and older—a group that constitutes a large percentage of the overall population—in the face of all-time-high levels of cardiovascular diseases, diabetes, cancer, and obesity.
While telehealth mainly has been applied to post-acute patients, providers are now looking to monitor the health of entire populations. This process, called population health management (PMH), is further expanding the total available market for telehealth. Other factors that will benefit the expansion of telehealth include the anticipated growth in wearable technology and the quantified self within a connected home context, aimed at developing a sustainable platform for preventive care.
Results from telehealth programs have revealed sharp decreases in readmission rates and mortality rates, alongside increases in adherence through patient engagement. These benefits make a strong business case for telehealth and will result in greater reimbursement from regulatory bodies. As a result, providers will integrate telehealth into their healthcare delivery. The introduction of mobile health hubs is also boosting the market, lowering the cost of telehealth while increasing overall value propositions.
“Amid rising expenses, an aging population, and the increasing prevalence of chronic diseases, the healthcare industry must change the way it operates,” said Roeen Roashan, medical devices and digital health analyst at IHS Technology. “Telehealth represents an attractive solution to these challenges, increasing the quality of care while reducing overall healthcare expenditures.”
The number of patients using telehealth services is expected to rise to 7 million by 2018, up from less than 350,000 in 2013. The subsequent worldwide revenue for telehealth devices and services is concomitantly expected to swell to USD 4.5 billion in 2018, up from USD 440.6 million in 2013.
Related Links:
IHS
Telehealth, defined as the use of medical devices and communication technology together to monitor diseases and symptoms, offers scalable healthcare in a cost-efficient way at a time of increasing pressure on the healthcare sector for personnel and resources. It is especially helpful in managing the chronic conditions of those aged 65 and older—a group that constitutes a large percentage of the overall population—in the face of all-time-high levels of cardiovascular diseases, diabetes, cancer, and obesity.
While telehealth mainly has been applied to post-acute patients, providers are now looking to monitor the health of entire populations. This process, called population health management (PMH), is further expanding the total available market for telehealth. Other factors that will benefit the expansion of telehealth include the anticipated growth in wearable technology and the quantified self within a connected home context, aimed at developing a sustainable platform for preventive care.
Results from telehealth programs have revealed sharp decreases in readmission rates and mortality rates, alongside increases in adherence through patient engagement. These benefits make a strong business case for telehealth and will result in greater reimbursement from regulatory bodies. As a result, providers will integrate telehealth into their healthcare delivery. The introduction of mobile health hubs is also boosting the market, lowering the cost of telehealth while increasing overall value propositions.
“Amid rising expenses, an aging population, and the increasing prevalence of chronic diseases, the healthcare industry must change the way it operates,” said Roeen Roashan, medical devices and digital health analyst at IHS Technology. “Telehealth represents an attractive solution to these challenges, increasing the quality of care while reducing overall healthcare expenditures.”
The number of patients using telehealth services is expected to rise to 7 million by 2018, up from less than 350,000 in 2013. The subsequent worldwide revenue for telehealth devices and services is concomitantly expected to swell to USD 4.5 billion in 2018, up from USD 440.6 million in 2013.
Related Links:
IHS
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Latest Business News
- Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
- World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
- Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
- Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreCritical Care
view channel
Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read more
Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening
Obstructive sleep apnea occurs when the upper airway becomes blocked during sleep, repeatedly stopping or restricting breathing. The disorder often goes undiagnosed, leaving untreated individuals at increased... Read moreSurgical Techniques
view channelFDA Approval Expands Bridging Stent Use in Complex Aortic Aneurysm Repair
Complex aortic aneurysms are increasingly treated with fenestrated and branched endovascular aortic repair, which rely on bridging stents to maintain blood flow to visceral arteries. These complex procedures... Read more
New Beam Measurement Approach Could Support More Precise Ion Therapy
Ion beam therapy uses accelerated atomic nuclei to damage cancer cells while limiting exposure to surrounding tissue. However, organ motion can shift where the beam deposits most of its energy by a few millimeters.... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease
Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more
Privacy-Preserving Learning Model Adapts Adult Radiology AI for Neonatal Care
Artificial intelligence models may support radiology image interpretation, yet pediatric and neonatal care remain underserved. Privacy restrictions limit access to children’s medical records, and pediatric... Read more
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more







